Page
%P
-
Article
Kee** ILCs in shape: PD-1 as a metabolic checkpoint
Anti-PD-1 immunotherapy has emerged as a revolutionary therapeutic strategy against cancer. However, it often leads to undesired side effects. In this issue, a new study reports how PD-1 signalling drives meta...